It is possible new templates exist for this target since these models were created.
Available Structures
14 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM structure of the J-K-St region of EMCV IRES in complex with eIF4G-HEAT1 and eIF4A |
Heteromer P60842; | 3×MG; | ||||
| Assess | ||||||
| Structure of a human 48S translational initiation complex |
Heteromer O00303; O15371; O15372; O75821; O75822; P05198; P08708; P08865; P15880; P20042; P23396; P25398; P39019; P41091; P41567; P42677; P46781; P46782; P46783; P47813; P55884; P60228; P60842; P60866; P61247; P62081; P62241; P62244; P62249; P62263; P62266; P62269; P62273; P62277; P62280; P62701; P62753; P62841; P62847; P62851; P62854; P62857; P62861; P62945; P62979; P63220; P63244; Q13347; Q14152; Q7L2H7; Q99613; Q9UBQ5; Q9Y262; | 2×ZN; 89×MG; | ||||
| Assess | ||||||
| Structure of a human 48S translation initiation complex with eIF4F and eIF4A |
Heteromer O00303; O15371; O15372; O75821; P05198; P08708; P08865; P15880; P20042; P23396; P25398; P39019; P41091; P42677; P46781; P46782; P46783; P47813; P55010; P55884; P60228; P60842; P60866; P61247; P62081; P62241; P62244; P62249; P62263; P62266; P62269; P62273; P62277; P62280; P62701; P62753; P62841; P62847; P62851; P62854; P62857; P62861; P62945; P62979; P63220; P63244; Q13347; Q14152; Q7L2H7; Q99613; Q9UBQ5; Q9Y262; | 2×ZN; 89×MG; | ||||
| Assess | ||||||
| Crystal structure of the human eIF4E-eIF4G complex |
Heteromer P06730; | 1×MGP; 2×GOL; | ||||
| Assess | ||||||
| Recognition of eIF4G by Rotavirus NSP3 reveals a basis for mRNA circularization |
Heteromer P03536; | 3×AU; | ||||
| Assess | ||||||
| Crystal structure of the PABP-binding site of eIF4G in complex with RRM1-2 of PABP and poly(A) |
Heteromer P11940; | |||||
| Assess | ||||||
| Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer P06730; | 1×5O8; 1×SO4; | ||||
| Assess | ||||||
| Stapled-peptides tailored against initiation of translation |
Heteromer P06730; | 1×MGT; | ||||
| Assess | ||||||
| Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer P06730; | 1×5NX; | ||||
| Assess | ||||||
| Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer P06730; | 1×5O8; 1×SO4; | ||||
| Assess | ||||||
| Crystal Structure of eIF4E Bound to Glycerol and eIF4G1 peptide |
Heteromer P06730; | 1×MGO; 1×PGE; 4×SO4; 2×GOL; | ||||
| Assess | ||||||
| Improved eIF4E binding peptides by phage display guided design. |
Heteromer P06730; | 1×MGO; | ||||
| Assess | ||||||
| C-terminal portion of human eIF4GI | monomer | |||||
| Assess | ||||||
| Cryo-EM structure of the J-K-St region of EMCV IRES in complex with eIF4G-HEAT1 and eIF4A (J-K-St/e… | monomer | 3×MG; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1ug3.1.A | monomer | 0.85 | 100.00 | |||
| Assess | ||||||
| 8oz0.1.u | monomer | 0.71 | 99.93 | |||
| Assess | ||||||
| 1hu3.1.A | monomer | 0.68 | 84.31 | |||
| Assess | ||||||